1. Home
  2. VTEX vs AMPH Comparison

VTEX vs AMPH Comparison

Compare VTEX & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTEX
  • AMPH
  • Stock Information
  • Founded
  • VTEX 1999
  • AMPH 1996
  • Country
  • VTEX Cayman Islands
  • AMPH United States
  • Employees
  • VTEX N/A
  • AMPH N/A
  • Industry
  • VTEX Computer Software: Prepackaged Software
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTEX Technology
  • AMPH Health Care
  • Exchange
  • VTEX Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • VTEX 1.1B
  • AMPH 1.1B
  • IPO Year
  • VTEX 2021
  • AMPH 2014
  • Fundamental
  • Price
  • VTEX $4.05
  • AMPH $29.76
  • Analyst Decision
  • VTEX Buy
  • AMPH Buy
  • Analyst Count
  • VTEX 4
  • AMPH 5
  • Target Price
  • VTEX $8.33
  • AMPH $36.20
  • AVG Volume (30 Days)
  • VTEX 1.4M
  • AMPH 640.5K
  • Earning Date
  • VTEX 08-07-2025
  • AMPH 08-07-2025
  • Dividend Yield
  • VTEX N/A
  • AMPH N/A
  • EPS Growth
  • VTEX 48.79
  • AMPH N/A
  • EPS
  • VTEX 0.05
  • AMPH 2.68
  • Revenue
  • VTEX $230,497,000.00
  • AMPH $722,679,000.00
  • Revenue This Year
  • VTEX $11.98
  • AMPH $0.92
  • Revenue Next Year
  • VTEX $16.13
  • AMPH $5.55
  • P/E Ratio
  • VTEX $77.68
  • AMPH $11.13
  • Revenue Growth
  • VTEX 4.53
  • AMPH 1.37
  • 52 Week Low
  • VTEX $3.93
  • AMPH $20.39
  • 52 Week High
  • VTEX $8.03
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • VTEX 20.83
  • AMPH 75.54
  • Support Level
  • VTEX $3.93
  • AMPH $29.64
  • Resistance Level
  • VTEX $4.43
  • AMPH $31.23
  • Average True Range (ATR)
  • VTEX 0.24
  • AMPH 1.20
  • MACD
  • VTEX -0.17
  • AMPH 0.99
  • Stochastic Oscillator
  • VTEX 5.18
  • AMPH 86.44

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: